Deciphera Pharmaceuticals LLC Price on December 31, 2022

DCPHDelisted Stock  USD 13.32  0.36  2.63%   
If you're considering investing in Deciphera Stock, it is important to understand the factors that can impact its price. As of today, the current price of Deciphera Pharmaceuticals stands at 13.32, as last reported on the 25th of November, with the highest price reaching 13.71 and the lowest price hitting 13.16 during the day. We have found twenty-four technical indicators for Deciphera Pharmaceuticals LLC, which you can use to evaluate the volatility of the firm. Please confirm Deciphera Pharmaceuticals' Coefficient Of Variation of (1,098), standard deviation of 2.13, and Mean Deviation of 1.66 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Deciphera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
DCPH
Based on monthly moving average Deciphera Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Deciphera Pharmaceuticals by adding Deciphera Pharmaceuticals to a well-diversified portfolio.

Deciphera Pharmaceuticals Valuation on December 31, 2022

It is possible to determine the worth of Deciphera Pharmaceuticals on a given historical date. On December 31, 2022 Deciphera was worth 15.95 at the beginning of the trading date compared to the closed value of 16.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Deciphera Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Deciphera Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Deciphera Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Deciphera Pharmaceuticals' related companies.
 Open High Low Close Volume
  15.35    16.17    15.35    15.99    391,296  
12/30/2022
  15.95    16.43    15.72    16.39    582,562  
  16.48    16.69    15.86    15.94    334,725  
Backtest Deciphera Pharmaceuticals  |  Deciphera Pharmaceuticals History  |  Deciphera Pharmaceuticals Valuation   PreviousNext  
Open Value
15.95
16.39
Closing Value
15.95
Upside

Deciphera Pharmaceuticals Trading Date Momentum on December 31, 2022

On January 03 2023 Deciphera Pharmaceuticals LLC was traded for  15.94  at the closing time. The top price for the day was 16.69  and the lowest listed price was  15.86 . The trading volume for the day was 334.7 K. The trading history from January 3, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.75% . The overall trading delta against the current closing price is 33.44% .

Deciphera Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Deciphera Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Deciphera Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Deciphera financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Deciphera Pharmaceuticals Stock history

Deciphera Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Deciphera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Deciphera Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Deciphera Pharmaceuticals stock prices may prove useful in developing a viable investing in Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Deciphera Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.

Deciphera Pharmaceuticals Stock Technical Analysis

Deciphera Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Deciphera Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Deciphera Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Deciphera Pharmaceuticals Period Price Range

Low
November 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Deciphera Pharmaceuticals LLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Deciphera Pharmaceuticals November 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Deciphera Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Deciphera Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Deciphera Pharmaceuticals stock market strength indicators, traders can identify Deciphera Pharmaceuticals LLC entry and exit signals to maximize returns

Deciphera Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Deciphera Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Deciphera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Deciphera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Deciphera Stock

If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios